West Pharmaceutical stock enters earnings watch with USD 382.00 target
Published on 09/29/2026 at 10:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
West Pharmaceutical stock (ISIN US9523901012) was last quoted at USD 375.62 on the NYSE on September 28, 2026, up 1.40 percent from the prior close. The next earnings date gives the market a defined checkpoint: West Pharmaceutical Services is scheduled to report third-quarter 2026 results on October 22, 2026.
Analysts set USD 382.00 target
According to MarketBeat on September 25, 2026, fourteen brokerages assigned West Pharmaceutical Services a Moderate Buy consensus, including twelve Buy ratings and two Hold ratings. Their average 12-month price target was USD 382.00, placing the consensus just above the September 28 reference price.
The valuation signal is measured rather than dramatic. West Pharmaceutical stock stood at USD 375.62 against a 52-week high of USD 386.00 and a 52-week low of USD 223.83 on September 28, 2026, leaving the shares near the upper end of their yearly range.
Q2 revenue rose 13.8 percent
West's latest reported quarter supplied the fundamental support for that analyst view. MarketBeat reported that second-quarter 2026 revenue reached USD 872.3 million, up 13.8 percent from the prior-year quarter, while reported EPS was USD 2.37 versus a USD 2.08 consensus estimate.
Management's fiscal 2026 adjusted EPS guidance was USD 8.85 to USD 9.05, while third-quarter guidance was USD 2.14 to USD 2.24, according to MarketBeat. The comparison investors will test next is whether the Q3 result can extend the 13.8 percent revenue growth rate without weakening the full-year range.
October 22 sets the next test
The scheduled Q3 report will put the USD 8.85 to USD 9.05 full-year EPS range beside fresh demand and margin data. MarketBeat lists October 22, 2026, before the market opens, with an 8:00 a.m. ET conference call.
West supplies containment and delivery components, devices and services for injectable medicines. Its shares trade on the NYSE under WST and the company is included in the S&P 500, according to MyChesCo.
West Pharmaceutical stock stays near its high
West Pharmaceutical stock was last quoted at USD 375.62 on the NYSE on September 28, 2026 at 3:59 p.m. ET. Its market capitalization was USD 26.4 billion, with 562,138 shares traded in that session.
West Pharmaceutical Services stock facts
- Company: West Pharmaceutical Services, Inc.
- ISIN: US9523901012
- Ticker: WST
- Trading venue: NYSE
- Price (as of September 28, 2026, 3:59 p.m. ET): USD 375.62
- Market capitalization: USD 26.4 billion (as of September 28, 2026)
- 52-week range: USD 223.83-386.00 (as of September 28, 2026)
- Sector / Industry: Healthcare / Medical instruments and supplies
- Index membership: S&P 500
- Next earnings date: October 22, 2026
